Cargando…

Role of IL-6 in Severe Inflammation

Detalles Bibliográficos
Autores principales:	Inoue, Ken-ichiro, Sagawa, Tomoya, Takano, Hirohisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781143/ https://www.ncbi.nlm.nih.gov/pubmed/32955926 http://dx.doi.org/10.1164/rccm.202007-3001LE

Ejemplares similares

COVID-19 and Coagulopathy
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)

Use of protease inhibitors for the prevention of COVID-19
por: Sagawa, Tomoya, et al.
Publicado: (2020)

Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitors
por: Sagawa, Tomoya, et al.
Publicado: (2020)

Aggravating Impact of Nanoparticles on Immune-Mediated Pulmonary Inflammation
por: Inoue, Ken-Ichiro, et al.
Publicado: (2011)

Systemic IL-6 and Severe Asthma
por: Lipworth, Brian, et al.
Publicado: (2020)

Is IL-6 the Right Target in COVID-19 Severe Pneumonia?
por: Blot, Mathieu, et al.
Publicado: (2021)

Authors' Reply to Comments from Dr. Guan
por: Inoue, Ken-ichiro, et al.
Publicado: (2009)

Particulate Matter–Induced Health Effects: Who Is Susceptible?
por: Inoue, Ken-ichiro, et al.
Publicado: (2011)

Environmental pollution and allergies
por: Takano, Hirohisa, et al.
Publicado: (2017)

Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
por: Sgherza, Nicola, et al.
Publicado: (2021)

Effects of nano particles on antigen-related airway inflammation in mice
por: Inoue, Ken-ichiro, et al.
Publicado: (2005)

Effects of Airway Exposure to Nanoparticles on Lung Inflammation Induced by Bacterial Endotoxin in Mice
por: Inoue, Ken-ichiro, et al.
Publicado: (2006)

Components of Diesel Exhaust Particles Diversely Enhance a Variety of Respiratory Diseases Related to Infection or Allergy: Extracted Organic Chemicals and the Residual Particles after Extraction Differently Affect Respiratory Diseases
por: Takano, Hirohisa, et al.
Publicado: (2007)

Candida soluble cell wall β-glucan facilitates ovalbumin-induced allergic airway inflammation in mice: Possible role of antigen-presenting cells
por: Inoue, Ken-ichiro, et al.
Publicado: (2009)

Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19
por: Garbers, Christoph, et al.
Publicado: (2021)

SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis
por: Njouendou, Abdel Jelil, et al.
Publicado: (2023)

Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply
por: Bovijn, Jonas, et al.
Publicado: (2021)

COVID-19: Clean up on IL-6
por: Hedrick, Tanner L., et al.
Publicado: (2020)

Biological Response-Enhancing Activity with Antigens in A549 Cells Exposed to Representative Polycyclic Aromatic Hydrocarbons
por: Misaki, Kentaro, et al.
Publicado: (2021)

Protective Effects of Urinary Trypsin Inhibitor on Systemic Inflammatory Response Induced by Lipopolysaccharide
por: Inoue, Ken-ichiro, et al.
Publicado: (2008)

Impact of Diesel Exhaust Particles on Th2 Response in the Lung in Asthmatic Mice
por: Inoue, Ken-ichiro, et al.
Publicado: (2008)

Metallothionein as an Anti-Inflammatory Mediator
por: Inoue, Ken-ichiro, et al.
Publicado: (2009)

Extensive Analysis of Elastase-Induced Pulmonary Emphysema in Rats: ALP in the Lung, a New Biomarker for Disease Progression?
por: Inoue, Ken-ichiro, et al.
Publicado: (2010)

Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients
por: Yang, Penghui, et al.
Publicado: (2021)

IL-33 and Airway Inflammation
por: Oboki, Keisuke, et al.
Publicado: (2011)

Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19
por: Bovijn, Jonas, et al.
Publicado: (2020)

Successful Treatment of Acrodermatitis Continua of Hallopeau with an Anti-IL-17A Agent
por: Inoue, Sae, et al.
Publicado: (2021)

Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Effects of Maternal Exposure to Di-(2-ethylhexyl) Phthalate during Fetal and/or Neonatal Periods on Atopic Dermatitis in Male Offspring
por: Yanagisawa, Rie, et al.
Publicado: (2008)

Di-(2-ethylhexyl) Phthalate Enhances Atopic Dermatitis-Like Skin Lesions in Mice
por: Takano, Hirohisa, et al.
Publicado: (2006)

Effects of Diisononyl Phthalate on Atopic Dermatitis in Vivo and Immunologic Responses in Vitro
por: Koike, Eiko, et al.
Publicado: (2010)

Differential Pattern of Cell Death and ROS Production in Human Airway Epithelial Cells Exposed to Quinones Combined with Heated-PM2.5 and/or Asian Sand Dust
por: Honda, Akiko, et al.
Publicado: (2023)

COVID-19 and intestinal inflammation: Role of fecal calprotectin
por: Ojetti, Veronica, et al.
Publicado: (2020)

Successful simultaneous targeting of IgE and IL-5 in a severe asthmatic patient selected for lung transplantation()
por: Bergmann, Karl-Christian, et al.
Publicado: (2022)

Short-Acting β(2)-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6
por: Nannini, Luis J.
Publicado: (2020)

Imaging of lung inflammation during severe influenza A: H1N1
por: Bellani, Giacomo, et al.
Publicado: (2010)

Systemic Immune-Inflammation Index (SII) Correlates with Disease Severity in Hidradenitis Suppurativa Patients
por: Hayran, Yıldız, et al.
Publicado: (2023)

Targeting IL-22 and IL-22R protects against experimental osteoarthritis
por: Yi, Changhua, et al.
Publicado: (2020)

Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
por: Xu, Jiao, et al.
Publicado: (2022)

Roles of IL-6-gp130 Signaling in Vascular Inflammation
por: Hou, Tieying, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1kkmgs8trke406tj7smt93p8cc